16-87888259-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001739.2(CA5A):c.788G>A(p.Arg263His) variant causes a missense change. The variant allele was found at a frequency of 0.000613 in 1,613,076 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00064 ( 15 hom. )
Consequence
CA5A
NM_001739.2 missense
NM_001739.2 missense
Scores
6
7
5
Clinical Significance
Conservation
PhyloP100: 6.61
Genes affected
CA5A (HGNC:1377): (carbonic anhydrase 5A) Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA VA is localized in the mitochondria and expressed primarily in the liver. It may play an important role in ureagenesis and gluconeogenesis. CA5A gene maps to chromosome 16q24.3 and an unprocessed pseudogene has been assigned to 16p12-p11.2. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.036411554).
BP6
Variant 16-87888259-C-T is Benign according to our data. Variant chr16-87888259-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1652614.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000388 (59/152142) while in subpopulation SAS AF= 0.0106 (51/4812). AF 95% confidence interval is 0.00828. There are 0 homozygotes in gnomad4. There are 43 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 15 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CA5A | NM_001739.2 | c.788G>A | p.Arg263His | missense_variant | 7/7 | ENST00000649794.3 | NP_001730.1 | |
CA5A | NM_001367225.1 | c.774+3540G>A | intron_variant | NP_001354154.1 | ||||
CA5A | NR_159798.1 | n.975G>A | non_coding_transcript_exon_variant | 8/8 | ||||
CA5A | NR_159799.1 | n.748G>A | non_coding_transcript_exon_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CA5A | ENST00000649794.3 | c.788G>A | p.Arg263His | missense_variant | 7/7 | NM_001739.2 | ENSP00000498065 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000388 AC: 59AN: 152026Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
59
AN:
152026
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00131 AC: 328AN: 250168Hom.: 5 AF XY: 0.00180 AC XY: 244AN XY: 135232
GnomAD3 exomes
AF:
AC:
328
AN:
250168
Hom.:
AF XY:
AC XY:
244
AN XY:
135232
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000637 AC: 930AN: 1460934Hom.: 15 Cov.: 31 AF XY: 0.000930 AC XY: 676AN XY: 726694
GnomAD4 exome
AF:
AC:
930
AN:
1460934
Hom.:
Cov.:
31
AF XY:
AC XY:
676
AN XY:
726694
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000388 AC: 59AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.000578 AC XY: 43AN XY: 74392
GnomAD4 genome
AF:
AC:
59
AN:
152142
Hom.:
Cov.:
32
AF XY:
AC XY:
43
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
175
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 08, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M;M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.
REVEL
Pathogenic
Sift
Pathogenic
D;.
Sift4G
Pathogenic
D;.
Polyphen
D;D
Vest4
MutPred
Loss of catalytic residue at R263 (P = 0.0956);Loss of catalytic residue at R263 (P = 0.0956);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at